Improvements in multiplex immunofluorescence and spatial analysis have enabled a better understanding of the ways classical Hodgkin lymphoma evades the immune system. Corresponding author Juan F.

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

Did you enjoy our In Focus, sponsored by Bethyl Laboratories, on multiplex immunofluorescence for cancer research? Now you can access it all in one downloadable feature! Introducing In Focus Wrapped, ...

Hamamatsu Photonics of Japan and Massachusetts-based Vizgen have announced a strategic partnership intended to speed up research laboratory workflows. The collaboration will in particular aim to ...

HAMBURG, Germany--(BUSINESS WIRE)--ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves ...

Over the past five years, the FCSC has invested $3.5 million in replacing or updating its instruments, expanding capacity, and developing new services such as multiplex immunofluorescence, Hanumanthu ...

Scientists have identified a new CAF subset in HNSCC using tissue cytometry and spatial transcriptomics. In two-thirds of cases, head and neck squamous cell carcinomas (HNSCC) require treatment with ...

(RTTNews) - Akoya Biosciences, Inc. (AKYA), Thursday announced the launch of a new multiplex immunofluorescence or mIF assay to advance antibody-drug conjugate or ADC development in breast cancer, ...